MaRS and J&J to support early-stage technologies

MaRS Innovation has teamed with Johnson & Johnson Corporate Office of Science and Technology to launch a co-managed and co-financed fund for early-stage development of Toronto-based life sciences technologies. Each party will commit a defined capital pool to support high-potential projects identified by a joint management committee. The objective is to take a technology to preliminary proof-of-concept within 12-24 months and leverage other resources as it moves towards commercialization through licensing or company creation….